Magnetic ferrocenyl-functionalized nanoparticle
US-10463391-B2 · Nov 5, 2019 · US
US12162001B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12162001-B2 |
| Application number | US-202418607097-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 15, 2024 |
| Priority date | Aug 23, 2022 |
| Publication date | Dec 10, 2024 |
| Grant date | Dec 10, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for making a magnetic-nanoparticle-supported catalyst includes reacting a ferrocenyl phosphine compound with an amino alcohol compound to form a ligand having a phosphine group, an amine group and at least one hydroxyl group; anchoring the ligand to a surface of magnetic nanoparticles via an oxygen atom of the hydroxyl group to form a ligand complex; combining the ligand complex with a metal precursor comprising Rh to bind the metal precursor with the ligand complex and form the magnetic-particle-supported catalyst. The magnetic-particle-supported catalyst is a Rh complex of magnetic-Fe3O4-nanoparticle-supported ferrocenyl phosphine catalyst.
Opening claim text (preview).
The invention claimed is: 1. A method for making a magnetic-nanoparticle-supported catalyst for hydrogen transfer and hydroformylation reactions, comprising: reacting a ferrocenyl phosphine compound with an amino alcohol compound to form a ligand having a ferrocene unit comprising a central iron atom, an unsubstituted cyclopentadienyl (Cp) ring, a substituted Cp ring substituted with (i) an alkyl group having an amine group and a phenyl group having at least one hydroxyl group, and (ii) one phosphine group; wherein the Cp ring and the alkyl substituted Cp ring are bound to the central iron atom; wherein the phosphine group is attached to the alkyl substituted Cp ring; anchoring the ligand to a surface of magnetic nanoparticles via an oxygen atom of the hydroxyl group to form a ligand complex; collecting the ligand complex with a magnet; combining the ligand complex with a metal precursor comprising Rh to bind the metal precursor with the ligand complex and form the magnetic-nanoparticle-supported catalyst. 2. The method of claim 1 , further comprising: acylating a ferrocene and reductive aminating with an alkylamine to provide an alkylamine substituted ferrocene; phosphorylating the alkylamine substituted ferrocene with an organophosphorus compound to provide an alkylamine substituted ferrocenyl phosphine; wherein the alkylamine substituted ferrocenyl phosphine comprises the phosphine group and an alkylamine group, and wherein the phosphine group and the alkylamine group are on the same Cp ring; acylating the alkylamine substituted ferrocenyl phosphine to provide the ferrocenyl phosphine compound. 3. The method of claim 2 , wherein: the alkylamine is dimethylamine; the organophosphorus compound is diphenylphosphine chloride; the alkylamine substituted ferrocenyl phosphine is N,N-dimethyl-1-[-2-(diphenyl phospheno)ferrocenyl]ethylamine (PPFA); the ferrocenyl phosphine compound is 1-[-2-(diphenyl phospheno)ferrocenyl]ethylacetate (PPFA-OAc); the amino alcohol compound is dopamine hydrochloride (dop); the ligand is dopamine ferrocenyl phosphine (dop-Fc); the magnetic nanoparticles are superparamagnetic Fe 3 O 4 nanoparticles, in the form of spheres; the ligand complex is a magnetic-Fe 3 O 4 -nanoparticle-supported dopamine ferrocenyl phosphine; the metal precursor is bicyclo[2.2.1]hepta-2,5-diene-rhodium(I) chloride dimer; and the magnetic-nanoparticle-supported catalyst is a Rh complex of the magnetic-Fe 3 O 4 -nanoparticle-supported dopamine ferrocenyl phosphine. 4. The method of claim 1 , further comprising: sonicating the magnetic nanoparticles to form a first suspension; mixing the ligand and the suspension, and sonicating to form a second suspension comprising ligand anchored magnetic nanoparticles; and wherein the magnetic nanoparticles are Fe 3 O 4 nanoparticles; wherein the ligand is dop-Fc; and wherein the ligand anchored magnetic nanoparticles are magnetic-Fe 3 O 4 -nanoparticle-supported dopamine ferrocenyl phosphine nanoparticles. 5. The method of claim 1 , wherein the magnetic-nanoparticle-supported catalyst has 0.2 to 0.3 mmol of Rh per gram of the catalyst. 6. The method of claim 1 , wherein the magnetic-nanoparticle-supported catalyst has a particle size in a longest dimension of 5 nm to 10 nm. 7. The method of claim 1 , wherein individual crystals of magnetite (Fe 3 O 4 ) within the magnetic-nanoparticle-supported catalyst have an interplanar distance of 0.2 nm to 0.25 nm between the individual crystals. 8. The method of claim 7 , wherein the individual crystals of magnetite are uniformly distributed throughout the magnetic-nanoparticle-supported catalyst. 9. The method of claim 1 , wherein the magnetic-nanoparticle-supported catalyst has a crystalline morphology.
Nanoparticles · CPC title
Indexing scheme associated with group B01J35/00, related to the analysis techniques used to determine the catalysts form or properties · CPC title
Scanning electron microscopy; Transmission electron microscopy · CPC title
X-ray diffraction · CPC title
comprising aliphatic or saturated rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.